# EDGAR Filing Document

**Accession Number:** 0001889791
**File Stem:** 0001493152-25-016465
**Filing Date:** 2025-10
**Character Count:** 2692
**Document Hash:** 366cab5c3697b3d96c3a06f3b1486cbd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-016465.hdr.sgml**: 20251001

**ACCESSION NUMBER**: 0001493152-25-016465

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 33

**FILED AS OF DATE**: 20251001

**DATE AS OF CHANGE**: 20251001

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INNOCAN PHARMA Corp
- **CENTRAL INDEX KEY:** 0001889791
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-288899
- **FILM NUMBER:** 251362534

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1015, 926 - 5 AVENUE SW
- **CITY:** CALGARY
- **PROVINCE COUNTRY:** Z4
- **ZIP:** T2P 0N7
- **BUSINESS PHONE:** 403-777-1519

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1015, 926 - 5 AVENUE SW
- **CITY:** CALGARY
- **PROVINCE COUNTRY:** Z4
- **ZIP:** T2P 0N7
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INNOCAN PHARMA Corp
- **CENTRAL INDEX KEY:** 0001889791
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1015, 926 - 5 AVENUE SW
- **CITY:** CALGARY
- **PROVINCE COUNTRY:** Z4
- **ZIP:** T2P 0N7
- **BUSINESS PHONE:** 403-777-1519

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1015, 926 - 5 AVENUE SW
- **CITY:** CALGARY
- **PROVINCE COUNTRY:** Z4
- **ZIP:** T2P 0N7

**Filed Pursuant to Rule 433**

**Issuer Free Writing Prospectus**

**October 1, 2025**

**Relating to Preliminary Prospectus**

**Dated September 30, 2025**

**Registration No. 333-288899**

![](formfwp_001.jpg)

![](formfwp_002.jpg)

![](formfwp_003.jpg)

![](formfwp_004.jpg)

![](formfwp_005.jpg)

![](formfwp_006.jpg)

![](formfwp_007.jpg)

![](formfwp_008.jpg)

![](formfwp_009.jpg)

![](formfwp_010.jpg)

![](formfwp_011.jpg)

![](formfwp_012.jpg)

![](formfwp_013.jpg)

![](formfwp_014.jpg)

![](formfwp_015.jpg)

![](formfwp_016.jpg)

![](formfwp_017.jpg)

![](formfwp_018.jpg)

![](formfwp_019.jpg)

![](formfwp_020.jpg)

![](formfwp_021.jpg)

![](formfwp_022.jpg)

![](formfwp_023.jpg)

![](formfwp_024.jpg)

![](formfwp_025.jpg)

![](formfwp_026.jpg)

![](formfwp_027.jpg)

![](formfwp_028.jpg)

![](formfwp_029.jpg)

![](formfwp_030.jpg)

![](formfwp_031.jpg)

![](formfwp_032.jpg)